Luis Alvarez-Vallina

19PUBLICATIONS
122CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursGene and molecular therapyMolecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Oct 27, 2025
Simultaneous secretion of a PD-L1 x 4-1BB bispecific antibody improves antileukemic efficacy of STAb-T cells secreting a CD19-specific T-cell engager.

Marina Gómez-Rosel, Laura Rubio-Pérez, Ivana Zagorac

|Apr 30, 2025
CD22 CAR-T cells secreting CD19 T-cell engagers for improved control of B-cell acute lymphoblastic leukemia progression.

Javier Arroyo-Ródenas, Aida Falgas, Laura Díez-Alonso

|Mar 16, 2025
A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR T-cell therapy in B-cell acute lymphoblastic leukemia.

Aïda Falgàs, Rodrigo Lázaro-Gorines, Samanta Romina Zanetti

|Dec 26, 2024
Dual-targeted STAb-T cells secreting BCMA and CD19 T cell engagers for improved control of haematological cancers.

Miriam Velasco-Sidro, Javier Arroyo-Ródenas, Laura Díez-Alonso

|Aug 29, 2024
CD4+ tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts.

Anaïs Jiménez-Reinoso, Magdalena Molero-Abraham, Cristina Cirauqui

|May 28, 2024
Characterization of a Trispecific PD-L1 Blocking Antibody That Exhibits EGFR-Conditional 4-1BB Agonist Activity.

Laura Rubio-Pérez, Susana Frago, Marta Compte

Pageof 4

Frequent Collaborators

9 joint publications

Marta Compte

9 joint publications

Laura Sanz

8 joint publications

Belén Blanco

7 joint publications

Laura Díez-Alonso